BioCentury
ARTICLE | Company News

Millennium, Bayer deal

October 30, 2000 8:00 AM UTC

MLNM said it has delivered more than 70 disease-relevant validated drug targets to BAYG for high throughput screening or lead identification under the companies' alliance, for which it has received fe...